Latest News for: crispr

Edit

Preliminary Proxy Statement (Form PRE 14A) (CRISPR Therapeutics AG)

Public Technologies 03 Apr 2025
Unless otherwise stated, all references to "us," "our," "CRISPR," "CRISPR Therapeutics," "we," the "Company" and similar designations refer ...
Edit

Plant Breeding and CRISPR Plants Market Overview, Share, Latest Trends, Growth Drivers, Key Segments, Leading ...

GetNews 02 Apr 2025
Climate change is significantly shaping the plant breeding and CRISPR plants market by increasing the need for resilient crop varieties ... South America is expected to witness significant growth in the plant breeding and CRISPR plants market.
Edit

Plant Breeding and CRISPR Plants Market worth $13.86 billion by 2030 (Markets and Markets Limited)

Public Technologies 31 Mar 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 123352862) .
Edit

Plant Breeding and CRISPR Plants Market worth $13.86 billion by 2030- Exclusive Report by MarketsandMarkets™

PR Newswire 31 Mar 2025
Climate change is significantly shaping the plant breeding and CRISPR plants market by increasing the need for resilient crop varieties ... Browse in-depth TOC on "Plant Breeding and CRISPR Plants Market"357 – Tables65 – Figures426 – Pages.
Edit

Abu Dhabi unveils UAE’s 1st CRISPR/Cas9 gene-editing therapy

GCC Business News 29 Mar 2025
The Department of HealthAbu Dhabi (DoH) has unveiled CASGEVY, the UAE’s first CRISPR/Cas9 gene-editing therapy for patients suffering from sickle cell disease (SCD) and transfusion dependent beta-thalassemia (TDT).
Edit

New light-controlled CRISPR tool enhances precision in genetic research

Phys Dot Org 28 Mar 2025
... allows researchers to control the gene-editing tool CRISPR using light.
Edit

ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement

Longview News-Journal 27 Mar 2025
License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation sequencing capabilities ....
Edit

CRISPR Therapeutics Announces Transition of Chief Operating Officer (Form 8-K) (CRISPR Therapeutics AG)

Public Technologies 26 Mar 2025
CRISPR Therapeutics Announces Transition of Chief Operating Officer. ZUG, Switzerland and BOSTON, March 26, 2025 -- CRISPR Therapeutics (Nasdaq ... Officer of CRISPR Therapeutics ... About CRISPR Therapeutics.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (CRISPR Therapeutics AG)

Public Technologies 24 Mar 2025
) FORM 4 ... 0.5 ... 2 ... CRISPR Therapeutics AG [CRSP] 5 ... C/O CRISPR THERAPEUTICS, 105 WEST FIRST STREET 3 ... C/O CRISPR THERAPEUTICS ... CRISPR Therapeutics AG published this content on March 24, 2025, and is solely responsible for the information contained therein.
×